Associated Papers
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y et al.
Hematological Oncology, 2022
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Y et al.
British Journal of Haematology, 2021
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.
Fujii K et al.
The Journal of Pathology. Clinical Research, 2021
Select a paper to view details